BRAF (V600E) mutation in isthmic malignant thyroid nodules

被引：3
|
作者：
Campenni, A. [1 ]
Giovanella, L. [2 ,3 ]
Alibrandi, A. [4 ]
Siracusa, M. [1 ]
Ruggeri, R. M. [5 ]
Baldari, S. [1 ]
机构：
[1] Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy
[2] Oncol Inst So Switzerland, Nucl Med, Bellinzona, Switzerland
[3] Oncol Inst So Switzerland, PET CT Ctr, Bellinzona, Switzerland
[4] Univ Messina, Dept Econ Business & Environm Sci & Quantitat Met, Messina, Italy
[5] Univ Messina, Dept Clin & Expt Med & Pharmacol, Endocrinol Sect, Messina, Italy
来源：
CLINICAL ENDOCRINOLOGY | 2016年 / 84卷 / 01期
关键词：
RISK; ABLATION; CANCER;
D O I：
10.1111/cen.12858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [41] Diagnostic value of puncture feeling combined with BRAF V600E mutation in repeat US-FNA biopsy of Bethesda III thyroid nodules
    Li Li
    Li, Peipei
    Chen, Xiao
    Kang, Lin
    Ye, Yuquan
    GLAND SURGERY, 2021, 10 (06) : 2019 - 2027
  • [42] BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
    Cong, Rong
    Ouyang, Hui
    Zhou, Di
    Li, Xinying
    Xia, Fada
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [43] Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues
    Daglar-Aday, Aynur
    Toptas, Bahar
    Ozturk, Tulin
    Seyhan, Fatih
    Saygili, Neslihan
    Eronat, Allison Pinar
    Akadam-Teker, Basak
    Yilmaz-Aydogan, Hulya
    Aksoy, Figen
    Ozturk, Oguz
    DNA AND CELL BIOLOGY, 2013, 32 (01) : 13 - 18
  • [44] Clinical and histopathological profile of BRAF V600E mutation in conventional papillary thyroid carcinoma in a Filipino population
    Navarro-Locsin, Cecilia Gretchen
    Chang, Ann Margaret Villarosa
    Daroy, Luisa
    Alfon, Alicia Cornista
    Andal, Jose Jasper
    Padua, Paula Francezca
    MALAYSIAN JOURNAL OF PATHOLOGY, 2016, 38 (02) : 141 - 148
  • [45] Relationship between BRAF V600E gene mutation and the clinical and pathologic characteristics of papillary thyroid microcarcinoma
    Ji, Wei
    Xie, Hong
    Wei, Bojun
    Shen, Hong
    Liu, Aizhu
    Gao, Ying
    Wang, Lingling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3492 - 3499
  • [46] Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience
    Kure, Shoko
    Ishino, Kousuke
    Kudo, Mitsuhiro
    Wada, Ryuichi
    Saito, Marie
    Nagaoka, Ryuta
    Sugitani, Iwao
    Naito, Zenya
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (11) : 5560 - 5572
  • [47] BRAF V600E Does Not Predict Aggressive Features of Pediatric Papillary Thyroid Carcinoma
    Givens, Daniel J.
    Buchmann, Luke O.
    Agarwal, Archana M.
    Grimmer, Johannes F.
    Hunt, Jason P.
    LARYNGOSCOPE, 2014, 124 (09) : E389 - E393
  • [48] Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAF V600E Mutation in Papillary Thyroid Carcinoma
    Kim, Jong-Kyu
    Seong, Chan Yong
    Bae, In Eui
    Yi, Jin Wook
    Yu, Hyeong Won
    Kim, Su-jin
    Won, Jae-Kyung
    Chai, Young Jun
    Choi, June Young
    Lee, Kyu Eun
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1775 - 1781
  • [49] The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis
    Li, Jianhua
    Zhang, Shuijun
    Zheng, Shouhua
    Zhang, Danhua
    Qiu, Xinguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (12): : 22246 - U565
  • [50] Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting
    Hilhorst, Riet
    van den Berg, Adrienne
    Boender, Piet
    van Wezel, Tom
    Kievits, Tim
    de Wijn, Rik
    Ruijtenbeek, Rob
    Corver, Willem E.
    Morreau, Hans
    CANCERS, 2023, 15 (18)
12345